Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Towards Personalized Medicine for Refractory/Relapsed Follicular Lymphoma Patients: the Cantera/Lupiae Registry

NCT04587388 is registered in ClinicalTrials.gov with European Hematology Association - Lymphoma Group as lead sponsor.

NCT NCT04587388
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04587388 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Towards Personalized Medicine for Refractory/Relapsed Follicular Lymphoma Patients: the Cantera/Lupiae Registry
Lead sponsor
European Hematology Association - Lymphoma Group
Phase
Observational
Overall status
Unknown status
Start date
May 22, 2019
Completion date
May 22, 2026
Enrollment
500 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

follicular lymphoma, relapsed/refractory follicular lymphoma